Significance and possible causes of hormone receptor expression loss in metastatic breast cancer. Phenotypic evolution of luminal &lt;i&gt;BRCA1&lt;/i&gt;-associated breast cancer to triple negative subtype in lung metastasis and PARP inhibition strategy in early-line therapy
Opuholi ženskoj reproduktivnoj sistemy